In order to understand the quality of active pharmaceutical ingredients from pharmaceutical plant in Taiwan, 20 samples were collected from the imported pharmaceutical dosage manufacturers by local health officers in Taiwan from July to September in 2010. These samples were analyzed for acarbose and meloxicam by referring to the respective monographs as described in the USP 32, and also analyzed for 9 residue solvents. The results showed that all met the requirements of USP 32 specification.